Sawai Pharm Placement - Dilution & Negative Sentiment Should Be Priced in After 18% Price Correction
Sawai Pharmaceutical Co Ltd (4555 JP) is looking to raise US$314m by selling 5m primary shares and 1m treasury shares (with 900,000...
200 Views
Death Rattle for Defensives?
While it is not a given that a switch from a high growth, high interest rate environment to a low growth, low interest rate environment is a good...
1k Views
Opdivo Singled Out in Government Rule Change
The suggestion of government orchestration against Ono’s immunotherapy treatment Opdivo (nivolumab) has moved a stage further with a report in the...
5.7k Views